TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34551207

Group type: EXPERIMENTAL
Intervention: Reduced sodium diet for 8 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual sodium diet
Number of subjects: 50
Study: 35618299

Group type: EXPERIMENTAL
Intervention: Physical education intervention program (three 10-minute weekly medium- to high-intensity activities for one academic year)
Number of subjects: 295

Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Physical education intervention program
Number of subjects: 295
Study: 33617910

Group type: EXPERIMENTAL
Intervention: Simultaneous Integrated Boost (SIB)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Sequential Boost (SEB)
Number of subjects: 150
Study: 32730136

Group type: EXPERIMENTAL
Intervention: Psychological support based on positive suggestion (PSBPS)
Number of subjects: 20
Study: 34923697

Group type: EXPERIMENTAL
Intervention: Digital story (video-based approach)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Written brief (control group)
Number of subjects: 20
Study: 33862265

Group type: EXPERIMENTAL
Intervention: FAE cycles with EF
Number of subjects: 1204

Group type: COMPARATOR
Intervention: Controls (fresh autologous IVF cycles)
Number of subjects: 1204
Study: 36175457

Group type: EXPERIMENTAL
Intervention: IRIS-enhanced VLE (IRIS-VLE)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Unenhanced VLE (VLE-IRIS)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Unenhanced VLE (IRIS-VLE)
Number of subjects: 133
Study: 35927580

Group type: EXPERIMENTAL
Intervention: Levodopa (L-DOPA; 250 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 32634344

Group type: EXPERIMENTAL
Intervention: Crohn's disease (CD)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Control group (without CD)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Patients with PG and CD
Number of subjects: 302
Study: 35459133

Group type: EXPERIMENTAL
Intervention: Exposure to traumatic events in adulthood only
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: No exposure to traumatic events
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Acting with awareness
Number of subjects: 245
Study: 34810392

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Collagen
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite
Number of subjects: 36

Group type: COMPARATOR
Intervention: Periapical bleeding
Number of subjects: 36
Study: 33215456

Group type: COMPARATOR
Intervention: 5-aminosalicylic acid (5-ASA)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA)
Number of subjects: 46
Study: 36484921

Group type: EXPERIMENTAL
Intervention: Shexiang Baoxin Pill combined with home‐based exercise training based on conventional drugs for 12 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Conventional drugs combined with home‐based exercise training for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional drug treatment only
Number of subjects: 60
Study: 33899331

Group type: EXPERIMENTAL
Intervention: Near-infrared light (NIL) therapy combined with meibomian gland expression (MGX)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Intense pulsed light (IPL) therapy combined with meibomian gland expression (MGX)
Number of subjects: 130
Study: 35445847

Group type: EXPERIMENTAL
Intervention: vonoprazan 10 mg every other day + clopidogrel 75 mg daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: vonoprazan 10 mg daily + clopidogrel 75 mg daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: clopidogrel 75 mg daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: vonoprazan 10 mg every other day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: vonoprazan 10 mg daily
Number of subjects: 12
Study: 34524406

Group type: EXPERIMENTAL
Intervention: Sirolimus (target serum levels, 4-12 ng/mL)
Number of subjects: 59
Study: 33646819

Group type: EXPERIMENTAL
Intervention: In-bore biopsy
Number of subjects: 286
Study: 33421079

Group type: EXPERIMENTAL
Intervention: Healthy marketing strategies implemented in 16 intervention stores for 18 months, including increased availability of healthier 'target' products, prime shelf-placement, call-out promotion signs, and reduced availability of regular 'comparison' products.
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Healthy marketing strategies in intervention stores.
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Intercept surveys with customers.
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Grocery marketing environment assessments in the same six food categories.
Number of subjects: 33
Study: 34480785

Group type: EXPERIMENTAL
Intervention: Intensive intervention group (frequent nutritional education at every outpatient visit)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Usual intervention group (nutritional education once a year)
Number of subjects: 96
Study: 33223095

Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 1778

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1778
Study: 32324444

Group type: EXPERIMENTAL
Intervention: 25-utterance condition
Number of subjects: 220

Group type: COMPARATOR
Intervention: 50-utterance condition
Number of subjects: 220
Study: 34727201

Group type: EXPERIMENTAL
Intervention: L-carnitine 1000 mg/day
Number of subjects: 62
Study: 33248135

Group type: EXPERIMENTAL
Intervention: Immediate laser treatment
Number of subjects: 117

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 117
Study: 33382385

Group type: EXPERIMENTAL
Intervention: Desloratadine citrate disodium (DCD, 8.8 mg/day) + Vitamin D3 nasal drops (1.5x10^6 IU, once/week) for four weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Desloratadine citrate disodium (DCD, 8.8 mg/day)
Number of subjects: 60
Study: 36031651

Group type: EXPERIMENTAL
Intervention: Digital screening using a certified app on smartphones
Number of subjects: 5551

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 5551
Study: 33393042

Group type: EXPERIMENTAL
Intervention: Upfront CRS/HIPEC
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: NACT + CRS/HIPEC
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Salvage CRS/HIPEC
Number of subjects: 148
Study: 35022283

Group type: EXPERIMENTAL
Intervention: Wet-cupping therapy (hijama)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 13
Study: 34024878

Group type: EXPERIMENTAL
Intervention: Atorvastatin (statin group)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 231
Study: 36284274

Group type: EXPERIMENTAL
Intervention: Journey of the Brave programme (intervention group, n=31)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (n=59)
Number of subjects: 90
Study: 33547784

Group type: EXPERIMENTAL
Intervention: Atacicept 150 mg
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Atacicept 75 mg
Number of subjects: 253

Group type: COMPARATOR
Intervention: Placebo/Atacicept 150 mg
Number of subjects: 253
Study: 32045911

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering treatment
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard blood pressure lowering treatment
Number of subjects: 1000
Study: 35698748

Group type: EXPERIMENTAL
Intervention: Holistic birth support strategies
Number of subjects: 64
Study: 34488034

Group type: EXPERIMENTAL
Intervention: Pharmacist-led systematic review of medications for PIM detection using explicit and implicit methods; communication of appropriate therapeutic strategies to physicians.
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: Pharmacist-led systematic review of medications for PIM detection.
Number of subjects: 549

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 549
Study: 32517596

Group type: EXPERIMENTAL
Intervention: Blended-learning course (5 hours of e-learning and 16 hours of near-peer tutoring)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Faculty-led 2.5-day ultrasound course
Number of subjects: 152
Study: 35983513

Group type: EXPERIMENTAL
Intervention: Online prediction model for primary aldosteronism (PA)
Number of subjects: 1314
Study: 34410617

Group type: EXPERIMENTAL
Intervention: Effort condition (Try Hard instructions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (no Try Hard instructions)
Number of subjects: 0
Study: 34225463

Group type: EXPERIMENTAL
Intervention: Core formulation regimen (test group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Non-compliant group (control group)
Number of subjects: 100
Study: 32247311

Group type: EXPERIMENTAL
Intervention: Community-initiated Kangaroo Mother Care (ciKMC)
Number of subjects: 552

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: ciKMC
Number of subjects: 552
Study: 35385591

Group type: EXPERIMENTAL
Intervention: Small text warnings
Number of subjects: 1360

Group type: EXPERIMENTAL
Intervention: Large text warnings
Number of subjects: 1360

Group type: EXPERIMENTAL
Intervention: Pictorial (image-and-text) warnings
Number of subjects: 1360

Group type: COMPARATOR
Intervention: Control (no warnings)
Number of subjects: 1360
Study: 32529563

Group type: EXPERIMENTAL
Intervention: Biofeedback
Number of subjects: 22

Group type: COMPARATOR
Intervention: Electrical stimulation
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 22
Study: 33236329

Group type: EXPERIMENTAL
Intervention: Gemtuzumab ozogamicin (GO) in combination with conventional induction chemotherapy
Number of subjects: 1000000

Group type: EXPERIMENTAL
Intervention: Gemtuzumab ozogamicin (GO) as monotherapy for newly diagnosed AML
Number of subjects: 1000000

Group type: EXPERIMENTAL
Intervention: Gemtuzumab ozogamicin (GO) as monotherapy for R/R AML
Number of subjects: 1000000
Study: 33090597

Group type: EXPERIMENTAL
Intervention: Sleep Restricted (5 hours per night)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Well Rested (8 hours per night)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both conditions (SR and WR)
Number of subjects: 31
Study: 34089923

Group type: EXPERIMENTAL
Intervention: Adaptive response inhibition training (n = 24)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Waitlist condition (n = 25)
Number of subjects: 49
Study: 33168097

Group type: EXPERIMENTAL
Intervention: Gamified e-learning module
Number of subjects: 98

Group type: COMPARATOR
Intervention: Current regional prehospital COVID‐19 guidelines (Control)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Gamified e-learning module (subgroup of actively working student paramedics)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Current regional prehospital COVID‐19 guidelines (subgroup of not actively working student paramedics) (Control)
Number of subjects: 98
Study: 36253105

Group type: EXPERIMENTAL
Intervention: Levodopa/carbidopa 300/75 mg daily for 80 weeks (early-start group)
Number of subjects: 445

Group type: COMPARATOR
Intervention: Placebo for 40 weeks followed by levodopa/carbidopa 300/75 mg daily for 40 weeks (delayed-start group)
Number of subjects: 445
Study: 33992261

Group type: EXPERIMENTAL
Intervention: Pilates and dark chocolate intake
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (dark chocolate without exercise)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Pilates and flavanol-free white chocolate
Number of subjects: 36
Study: 35685492

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet (MD)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Low-Fat Diet
Number of subjects: 129

Group type: COMPARATOR
Intervention: Regular Diet
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: All dietary groups
Number of subjects: 129
Study: 34287399

Group type: EXPERIMENTAL
Intervention: Internet-based teaching (computer-based multimedia recorded lecture, 3 hours)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Face-to-face teaching (live lecture, 3 hours)
Number of subjects: 36
Study: 36007448

Group type: EXPERIMENTAL
Intervention: EWA program (two‐year specialized woman only treatment including psychiatric, interpersonal and family concerns)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: EWA program
Number of subjects: 200

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) in a mixed gender setting
Number of subjects: 200
Study: 34085324

Group type: EXPERIMENTAL
Intervention: Peripheral muscle strength training (PMT) and respiratory muscle strength training (RMT) associated with conventional physical therapy, one session a day for 5 days.
Number of subjects: 83

Group type: COMPARATOR
Intervention: Conventional physical therapy, one session a day for 5 days.
Number of subjects: 83
Study: 32826049

Group type: EXPERIMENTAL
Intervention: IVF
Number of subjects: 0

Group type: COMPARATOR
Intervention: OC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 35606823

Group type: EXPERIMENTAL
Intervention: Blended physiotherapy program comprising six in-clinic physiotherapy sessions over a period of 12 weeks (1x/2 weeks) and an exercise and counselling program provided by the smartphone application.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care program comprising twelve weekly in-clinic physiotherapy sessions.
Number of subjects: 0
Study: 33063291

Group type: EXPERIMENTAL
Intervention: High GPC (D1+BAd107‐4)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Low GPC (CN16)
Number of subjects: 3
Study: 32703244

Group type: EXPERIMENTAL
Intervention: Tinnitus Retraining Therapy (TRT)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Partial Tinnitus Retraining Therapy (Partial TRT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 25
Study: 35320344

Group type: EXPERIMENTAL
Intervention: Strict restrictive fluid strategy with norepinephrine
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Positive end‐expiratory pressure
Number of subjects: 19
Study: 34948667

Group type: EXPERIMENTAL
Intervention: Training in hypoxic conditions
Number of subjects: 16

Group type: COMPARATOR
Intervention: Training in normoxic conditions
Number of subjects: 16
Study: 32521561

Group type: EXPERIMENTAL
Intervention: Formula feeding
Number of subjects: 2329

Group type: EXPERIMENTAL
Intervention: Maternal age <20 years
Number of subjects: 2329

Group type: EXPERIMENTAL
Intervention: Maternal age ≥35 years
Number of subjects: 2329

Group type: EXPERIMENTAL
Intervention: Never married status
Number of subjects: 2329

Group type: EXPERIMENTAL
Intervention: Government-assisted insurance
Number of subjects: 2329

Group type: EXPERIMENTAL
Intervention: Chronic hypertension
Number of subjects: 2329

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 2329

Group type: EXPERIMENTAL
Intervention: Cesarean delivery
Number of subjects: 2329

Group type: EXPERIMENTAL
Intervention: Admission to neonatal intensive care unit
Number of subjects: 2329

Group type: EXPERIMENTAL
Intervention: Hispanic ethnicity
Number of subjects: 2329

Group type: EXPERIMENTAL
Intervention: Education >12 years
Number of subjects: 2329

Group type: EXPERIMENTAL
Intervention: Nulliparity
Number of subjects: 2329
Study: 35907262

Group type: EXPERIMENTAL
Intervention: Active rTMS (10Hz)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Active WMT
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Active rTMS + Active WMT
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sham WMT
Number of subjects: 43
Study: 32089338

Group type: EXPERIMENTAL
Intervention: Bilateral mental incisive nerve block (MINB) of 1.8 mL of 2% lidocaine with 1:80,000 epinephrine
Number of subjects: 76

Group type: COMPARATOR
Intervention: Unilateral mental incisive nerve block (MINB) of 1.8 mL of 2% lidocaine with 1:80,000 epinephrine
Number of subjects: 76
Study: 35666322

Group type: EXPERIMENTAL
Intervention: Etidronate (20 mg/kg for 2 weeks on and 10 weeks off, orally for 12 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (similar routine as etidronate for 12 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Etidronate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33031636

Group type: EXPERIMENTAL
Intervention: Enzymatic toothpaste
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard fluoridated toothpaste
Number of subjects: 52
Study: 37317475

Group type: EXPERIMENTAL
Intervention: Flexible cystoscope with disposable sheath
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard flexible cystoscopy
Number of subjects: 60
Study: 35574454

Group type: EXPERIMENTAL
Intervention: Fixed-repetition group (adjusted band resistance to complete 10 repetitions at 7-RPE)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Open-repetition group (selected preferred band resistance and completed repetitions until reaching 7-RPE)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Combined pre-post change scores of both groups
Number of subjects: 57
Study: 32895286

Group type: EXPERIMENTAL
Intervention: Community-adapted Expecting intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 60
Study: 35584010

Group type: EXPERIMENTAL
Intervention: Physical Therapy (PT)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Education
Number of subjects: 230
Study: 32886811

Group type: EXPERIMENTAL
Intervention: 200,000 U polymyxin B + 40 mg neomycin solution in normal saline (antibiotic)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 216
Study: 34570061

Group type: EXPERIMENTAL
Intervention: Texting 4 Relapse Prevention (T4RP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 40
Study: 36268141

Group type: EXPERIMENTAL
Intervention: Intelligent management system
Number of subjects: 180
Study: 34580095

Group type: EXPERIMENTAL
Intervention: Pre-exposure prophylaxis (PrEP) characteristics preferences among TGW and MSM
Number of subjects: 1000
Study: 35211224

Group type: EXPERIMENTAL
Intervention: Remote-CR
Number of subjects: 11

Group type: COMPARATOR
Intervention: CB-CR
Number of subjects: 11
Study: 33018611

Group type: EXPERIMENTAL
Intervention: Real videos (40 trials)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Simulated videos (40 trials)
Number of subjects: 16
Study: 33904178

Group type: EXPERIMENTAL
Intervention: Fear assessment + brochure
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Fear assessment + brochure + tailored conversation
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Fear assessment
Number of subjects: 664

Group type: COMPARATOR
Intervention: Control
Number of subjects: 664
Study: 33371108

Group type: EXPERIMENTAL
Intervention: Enhancing quality of life intervention
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 35804078

Group type: EXPERIMENTAL
Intervention: Reflex locomotion therapy (RLT)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Passive movements with gentle joint compression
Number of subjects: 46

Group type: COMPARATOR
Intervention: Massages (Control)
Number of subjects: 46
Study: 34858228

Group type: EXPERIMENTAL
Intervention: C. militaris plus duloxetine
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo plus duloxetine
Number of subjects: 59
Study: 35248263

Group type: EXPERIMENTAL
Intervention: Diaphragmatic breathing exercises (Group DB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pelvic floor muscle exercises (Group PFM)
Number of subjects: 40
Study: 33934208

Group type: EXPERIMENTAL
Intervention: Electrical pudendal nerve stimulation (EPNS)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intravesical instillation (II) of heparin and alkalinized lidocaine
Number of subjects: 80
Study: 32684216

Group type: EXPERIMENTAL
Intervention: Higher level of PEEP (13-17 cmH2O)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Lower level of PEEP (8-12 cmH2O)
Number of subjects: 100
Study: 35786058

Group type: EXPERIMENTAL
Intervention: PRC-063
Number of subjects: 387

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 387
Study: 33148129

Group type: EXPERIMENTAL
Intervention: Panic Control Treatment (PCT)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Panic-Focused Psychodynamic Psychotherapy (PFPP)
Number of subjects: 109
Study: 33218296

Group type: EXPERIMENTAL
Intervention: Behavioral interventions involving electronic devices, financial incentives, gamification, and specially trained staff
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pragmatic clinical trials of behavioral interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 35679021

Group type: EXPERIMENTAL
Intervention: Cabozantinib 60 mg orally once daily
Number of subjects: 258

Group type: COMPARATOR
Intervention: Placebo with best supportive care
Number of subjects: 258
Study: 33906954

Group type: EXPERIMENTAL
Intervention: Home-based program with health coaching (8-week intervention, video-guided exercises 6 times a week, weekly health coaching over the telephone)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Home-based program with health coaching
Number of subjects: 154
Study: 32592725

Group type: EXPERIMENTAL
Intervention: High caloric food pictures
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Low caloric food pictures
Number of subjects: 35

Group type: COMPARATOR
Intervention: Neutral pictures
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Luteal phase
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Follicular and ovulatory phases
Number of subjects: 35
Study: 36174484

Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood pressure (SMBP)
Number of subjects: 24
Study: 33713841

Group type: EXPERIMENTAL
Intervention: 4-month treatment regimen
Number of subjects: 2500

Group type: COMPARATOR
Intervention: 6-month standard treatment regimen
Number of subjects: 2500
Study: 35726278

Group type: EXPERIMENTAL
Intervention: Forearm compression sleeves (COMP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Non-compressive placebo forearm sleeves (PLAC)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No forearm sleeves (CON)
Number of subjects: 24
Study: 35349038

Group type: EXPERIMENTAL
Intervention: Self-assessed poor health status (n = 21, 8%)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Self-assessed non-poor health status (n = 245, 92%)
Number of subjects: 400